Biotech

All Articles

Gene publisher Volume giving up 131 employees

.Just days after gene publisher Volume Biosciences declared undisclosed operational slices, a cleare...

Repare lays off 25% of staff as biotech standstills preclinical R&ampD

.Repare Rehab is actually laying off a fourth of its own labor force as the oncology biotech downsiz...

J &amp J apply for FDA permission of $6.5 B autoimmune medication

.Johnson &amp Johnson has gotten one more step towards noticing a return on its own $6.5 billion nip...

Gain's period 1 succeed paves method to show Parkinson's medicine's worth

.Increase Therapies has set its own direct showing the performance of its Parkinson's ailment treatm...

Actinogen records brand new phase 2 information to salvage clinical depression medication

.Actinogen Medical's hopes-- as well as stock cost-- have actually rebounded slightly coming from ea...

Pfizer and Flagship include Ratio to multibillion-dollar formula

.Main Pioneering and Pfizer have added Quotient in to their 10-program collaboration, inking a packa...

Bayer markers $547M deal to drive boundaries of noncoding RNA

.Bayer executives were eager to tension to Ferocious this summer that the German pharma giant's crav...

UK introduces strategies to introduce 18 brand new professional test hubs

.Amidst a yearslong clinical test decline in the U.K., a brand-new public-private collaboration has ...

UPDATE: Genentech telegrams 93 unemployments in The golden state after sharing strategies to shutter cancer immunology research unit

.Complying with the statement of a sizable cutback round in April as well as a significant restructu...

Neurocrine's KarXT competitor attacks in period 2-- but simply at reduced dose

.Neurocrine Biosciences has attained its own hoped-for account in a period 2 schizophrenia trial, de...